These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 34899631)

  • 41. Applications of the CRISPR-Cas system for infectious disease diagnostics.
    Li P; Wang L; Yang J; Di LJ; Li J
    Expert Rev Mol Diagn; 2021 Jul; 21(7):723-732. PubMed ID: 33899643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Function and regulation of clustered regularly interspaced short palindromic repeats (CRISPR) / CRISPR associated (Cas) systems.
    Richter C; Chang JT; Fineran PC
    Viruses; 2012 Oct; 4(10):2291-311. PubMed ID: 23202464
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CRISPR-Cas13 Precision Transcriptome Engineering in Cancer.
    Granados-Riveron JT; Aquino-Jarquin G
    Cancer Res; 2018 Aug; 78(15):4107-4113. PubMed ID: 30021724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CRISPR guides induce gene silencing in plants in the absence of Cas.
    Sharma VK; Marla S; Zheng W; Mishra D; Huang J; Zhang W; Morris GP; Cook DE
    Genome Biol; 2022 Jan; 23(1):6. PubMed ID: 34980227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clustered regularly interspaced short palindromic repeats (CRISPRs): the hallmark of an ingenious antiviral defense mechanism in prokaryotes.
    Al-Attar S; Westra ER; van der Oost J; Brouns SJ
    Biol Chem; 2011 Apr; 392(4):277-89. PubMed ID: 21294681
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Programmable RNA targeting with the single-protein CRISPR effector Cas7-11.
    Özcan A; Krajeski R; Ioannidi E; Lee B; Gardner A; Makarova KS; Koonin EV; Abudayyeh OO; Gootenberg JS
    Nature; 2021 Sep; 597(7878):720-725. PubMed ID: 34489594
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
    Ahmed MZ; Badani P; Reddy R; Mishra G
    J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A genomic sequence of the type II-A clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated system in
    Mizuki H; Shimoyama Y; Ishikawa T; Sasaki M
    J Oral Microbiol; 2022; 14(1):2008153. PubMed ID: 34992734
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CRISPR applications in cancer diagnosis and treatment.
    Wang M; Chen M; Wu X; Huang X; Yu B
    Cell Mol Biol Lett; 2023 Sep; 28(1):73. PubMed ID: 37674114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suppression of Borna Disease Virus Replication during Its Persistent Infection Using the CRISPR/Cas13b System.
    Sasaki S; Ogawa H; Katoh H; Honda T
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutations in Cas9 Enhance the Rate of Acquisition of Viral Spacer Sequences during the CRISPR-Cas Immune Response.
    Heler R; Wright AV; Vucelja M; Bikard D; Doudna JA; Marraffini LA
    Mol Cell; 2017 Jan; 65(1):168-175. PubMed ID: 28017588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alleviation of neurological disease by RNA editing.
    Zhang S; Chen L; Zhang Y; Fang D
    Methods; 2021 Oct; 194():94-99. PubMed ID: 33933604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methods for the Analysis and Characterization of Defense Mechanisms Against Horizontal Gene Transfer: CRISPR Systems.
    Calvo-Villamañán A; Bernheim A; Bikard D
    Methods Mol Biol; 2020; 2075():235-249. PubMed ID: 31584167
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comprehensive Mining and Characterization of CRISPR-Cas Systems in
    Pan M; Nethery MA; Hidalgo-Cantabrana C; Barrangou R
    Microorganisms; 2020 May; 8(5):. PubMed ID: 32408568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. On the Origin of Reverse Transcriptase-Using CRISPR-Cas Systems and Their Hyperdiverse, Enigmatic Spacer Repertoires.
    Silas S; Makarova KS; Shmakov S; Páez-Espino D; Mohr G; Liu Y; Davison M; Roux S; Krishnamurthy SR; Fu BXH; Hansen LL; Wang D; Sullivan MB; Millard A; Clokie MR; Bhaya D; Lambowitz AM; Kyrpides NC; Koonin EV; Fire AZ
    mBio; 2017 Jul; 8(4):. PubMed ID: 28698278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endogenous CRISPR-Cas System-Based Genome Editing and Antimicrobials: Review and Prospects.
    Li Y; Peng N
    Front Microbiol; 2019; 10():2471. PubMed ID: 31708910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Precise transcript targeting by CRISPR-Csm complexes.
    Colognori D; Trinidad M; Doudna JA
    Nat Biotechnol; 2023 Sep; 41(9):1256-1264. PubMed ID: 36690762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of CRISPR/cas system in the development of bacteriophage resistance.
    Szczepankowska A
    Adv Virus Res; 2012; 82():289-338. PubMed ID: 22420856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapidly Characterizing CRISPR-Cas13 Nucleases Using Cell-Free Transcription-Translation Systems.
    Wandera KG; Beisel CL
    Methods Mol Biol; 2022; 2404():135-153. PubMed ID: 34694607
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Substrate generation for endonucleases of CRISPR/cas systems.
    Zoephel J; Dwarakanath S; Richter H; Plagens A; Randau L
    J Vis Exp; 2012 Sep; (67):. PubMed ID: 22986408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.